Cancer clinical trials in the region Bourgogne-Franche-Comté
210 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Prostate cancer
#NCT05939414
Biochemical recurrence
Metastatic Hormone-sensitive
Surgery
Radiotherapy
PSMA PET Positive
Hôpital Louis Pradel (Bron ), Centre Henri Becquerel (Rouen ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud)
Novartis
Phase 3
Pancreas cancer
#NCT04919226
Neuroendocrine tumor
Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon), IUCT Oncopôle (Toulouse), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
ITM Solucin GmbH
Phase 3
Pancreas cancer
#NCT04167007
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
Hôpital privé Arras les Bonnettes - Ramsay Santé (Arras), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Assistance Publique - Hôpitaux de Paris
Phase 3
Lymphoma
#NCT05578976
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
CD20
Systemic Treatment-Naive
None
Hôpital Saint Louis AP-HP (Paris), Institut Paoli-Calmettes (Marseille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Grenoble (La Tronche), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 16 more...)
Abbvie
Phase 3
Lung cancer
#NCT06396065
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
EGFR
Targeted therapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Centre Léon Bérard (Lyon), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Institut Curie - Paris (Paris), Centre Hospitalier Intercommunal Créteil (Créteil Cedex)
Summit Therapeutics
Phase 3
Colon cancer
Rectal cancer
#NCT06293625
Adenocarcinoma
Locally Advanced
MSS
Systemic Treatment-Naive
MSI/dMMR
Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg), Centre Hospitalier Intercommunal Elbeuf - Louviers - Val de Reuil (Saint-Aubin-lès-Elbeuf), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Hôpital Jacques Puel - Bourran (Rodez) (and 56 more...)
CHU Dijon
Phase 3
Breast cancer
#NCT06018337
HER2 Low
HR Positive
Locally Advanced
Metastatic
Targeted therapy
Hormone therapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Hôpital Henri-Mondor AP-HP (Créteil), CHU Nîmes / Institut de cancérologie du Gard (Nîmes), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire Dupuytren (Limoges) (and 11 more...)
DualityBio Inc.
Phase 3
Lung cancer
#NCT06012435
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Bichat - Claude Bernard - AP-HP (Paris), Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre Hospitalier Universitaire de Lille (Lille), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 10 more...)
Seagen
Phase 3
Lymphoma
#NCT06006117
B cell lymphoma
Marginal zone lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), CHU Nice Hôpital l'Archet (Nice) (and 18 more...)
Organisation de recherche universitaire sur le lymphome
Phase 3
Lung cancer
#NCT05920356
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
PDL1 Negative (< 1%)
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille), Centre Hospitalier Universitaire de Nîmes (Nîmes), Institut Curie - Paris (Paris), CHU de Rennes - Hôpital Pontchaillou (Rennes) (and 18 more...)
Amgen